Literature DB >> 30719718

Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case-control study.

Mostafa Dianatinasab1, Mohammad Fararouei1, Nima Daneshi2, Shahab Rezaian3, Mohammad Mohammadianpanah4, Reza Chaman5, Reza Ghiasvand6.   

Abstract

Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) of the breast are the most common histological subtypes of breast cancer. However, the associations and heterogeneity between histological subtypes and their risk factors are not well established. This study aimed to investigate risk factors for IDC and ILC. This case-control study included 1,009 incident breast cancer cases and 1,009 hospital controls, frequency-matched by age. Data were obtained from the patients' medical files and an interview administered via a questionnaire. Multinomial logistic regression was used and odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. The heterogeneity of the associations was assessed using the Wald test. Family history of breast cancer was associated with IDC (OR 2.64, 95% CI: 1.97-3.55) but not ILC (OR 0.81, 95% CI: 0.42-1.57; p for heterogeneity <0.001). Conversely, a history of miscarriage was associated with ILC (OR 1.71, 95% CI: 1.17-2.51) but not IDC (OR 1.18, 95% CI: 0.95-1.46; p for heterogeneity = 0.04). Similarly, type 2 diabetes was associated with ILC but not IDC (p for heterogeneity = 0.02). Age at first delivery and breastfeeding were significantly associated with IDC but not ILC, though p values for heterogeneity did not reach the significance level. Deliberate weight loss and age at menarche were significantly associated with ILC but not IDC (p for heterogeneity ≥0.27). Smoking, history of benign breast disease and BMI were associated with both subtypes. The present study supports the hypothesis that IDC and ILC are etiologically distinct tumours.
© 2019 UICC.

Entities:  

Keywords:  ductal breast carcinoma; epidemiology; heterogeneity; lobular breast carcinoma; risk factors

Mesh:

Year:  2019        PMID: 30719718     DOI: 10.1002/ijc.32182

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Hereditary and breastfeeding factors are positively associated with the aetiology of mammary gland hyperplasia: a case-control study.

Authors:  Hanlu Gao; Chao Yang; Jinqing Fan; Li Lan; Da Pang
Journal:  Int Health       Date:  2021-04-27       Impact factor: 2.473

2.  Estrogen receptor-positive breast cancer survival prediction and analysis of resistance-related genes introduction.

Authors:  Chen Shuai; Fengyan Yuan; Yu Liu; Chengchen Wang; Jiansong Wang; Hongye He
Journal:  PeerJ       Date:  2021-10-26       Impact factor: 2.984

3.  The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women.

Authors:  Linus P Rweyemamu; Gokce Akan; Ismael C Adolf; Erick P Magorosa; Innocent J Mosha; Nazima Dharsee; Lucy A Namkinga; Sylvester L Lyantagaye; Abdolrahman S Nateri; Fatmahan Atalar
Journal:  BMC Womens Health       Date:  2021-12-20       Impact factor: 2.809

4.  Adherence to a western dietary pattern and risk of invasive ductal and lobular breast carcinomas: a case-control study.

Authors:  Elahe Foroozani; Mostafa Dianatinasab; Ali Akbari; Sasan Amanat; Nastaran Rashidi; Dariush Bastam; Shima Ataee; Golnaz Sharifnia; Mohammad Faraouei; Hassan Safdari
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

5.  Biomarkers for Breast Adenocarcinoma Using In Silico Approaches.

Authors:  Jhansi Pandi; Ajucarmelprecilla Arulprakasam; Ranjithkumar Dhandapani; Saikishore Ramanathan; Sathiamoorthi Thangavelu; Jayaprakash Chinnappan; V Vidhya Rajalakshmi; Saad Alghamdi; Nashwa Talaat Shesha; S Prasath
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.